Veit Scheble
Universitätsklinikum Tübingen(DE)University Children's Hospital Tübingen(DE)University of Tübingen(DE)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Cancer Immunotherapy and Biomarkers, Molecular Biology Techniques and Applications, Lung Cancer Treatments and Mutations
Most-Cited Works
- → SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas(2009)945 cited
- → SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer(2011)200 cited
- → Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma(2011)194 cited
- → Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort(2010)183 cited
- → SOX2 amplification is a common event in squamous cell carcinomas of different organ sites(2011)126 cited
- → ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor(2010)121 cited
- →